BioPortUSA to present to French based Wilco on Market Entry USA

WILCO is a French based start-up accelerator for medtech companies wishing to sell to the healthcare industry. They have invited BioPortUSA to present to a group of French medtech companies from throughout France. The webinar is scheduled for Tuesday, September 29 and will focus on how to prepare for market entry into the USA. A large part of the presentation will underscore the importance of cultural differences that exist, and how one needs to be able to adapt if one is going to find success in the USA.
 
This webinar will be particularly useful for new MedTech companies who are interested in expanding into the USA as well as those companies that already have a presence in America but could benefit from a refresher. Topics that will be covered include:

• The Complexity of the Market and the Changes Taking Place
• Managing Payers and Reimbursement
• Sales Strategy
• How Hospitals Buy
• The Role of Marketing and Branding in the US

In addition to the Webinar, BioPort will be offering free 30-minute one-on-one meetings with participating companies at a later date.
 

In 2017, after having accelerated over 1,000 Paris Region startups, Scientipôle Initiative and Croissance merged and WILCO was born. WILCO is a unique accelerator program offering 5 industry-specific tracks, helping selected innovative startups achieve their first million €uros in revenue within 3 years.